Overview
Gonadoblastoma is a rare gonadal neoplasm that arises almost exclusively in individuals with disorders of sex development (DSD) who carry Y chromosome material in their karyotype, most commonly those with 46,XY complete gonadal dysgenesis (Swyer syndrome), 45,X/46,XY mixed gonadal dysgenesis, or other forms of gonadal dysgenesis. The tumor is composed of a mixture of germ cells and sex cord-stromal cells resembling immature Sertoli and granulosa cells, typically arising in dysgenetic (streak) gonads. Gonadoblastoma itself is considered a benign or in situ neoplasm, but it carries significant clinical importance because approximately 50–60% of cases can progress to invasive malignant germ cell tumors, most commonly dysgerminoma (seminoma equivalent), and less frequently to other malignant germ cell tumors such as yolk sac tumor, embryonal carcinoma, or choriocarcinoma. Clinically, gonadoblastoma may be discovered incidentally during evaluation for primary amenorrhea, ambiguous genitalia, or delayed puberty in phenotypic females or undervirilized males. Some patients may present with signs of virilization due to testosterone production by the tumor. The tumor can be unilateral or bilateral, with bilateral involvement occurring in approximately 40% of cases. A susceptibility locus on the Y chromosome, termed the gonadoblastoma locus on the Y chromosome (GBY), has been identified, with the TSPY1 gene being a strong candidate for the critical gene involved in tumor development. The primary treatment for gonadoblastoma is prophylactic gonadectomy, which is recommended for individuals with gonadal dysgenesis who carry Y chromosome material, given the high risk of malignant transformation. When gonadoblastoma is identified, surgical removal of both gonads is typically advised, as bilateral disease is common. Following gonadectomy, hormone replacement therapy is necessary to support pubertal development and long-term bone and cardiovascular health. The prognosis for gonadoblastoma itself is excellent after complete surgical removal, though outcomes depend on whether malignant transformation has occurred prior to diagnosis. Regular surveillance and early intervention are key to preventing progression to invasive germ cell malignancies.
Clinical phenotype terms— hover any for plain English:
Variable
Can be inherited in different ways depending on the underlying gene
Variable
Can begin at different ages, from infancy through adulthood
Treatments
No FDA-approved treatments are currently listed for Gonadoblastoma.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Gonadoblastoma at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Gonadoblastoma.
Community
No community posts yet. Be the first to share your experience with Gonadoblastoma.
Start the conversation →Latest news about Gonadoblastoma
No recent news articles for Gonadoblastoma.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Gonadoblastoma
What is Gonadoblastoma?
Gonadoblastoma is a rare gonadal neoplasm that arises almost exclusively in individuals with disorders of sex development (DSD) who carry Y chromosome material in their karyotype, most commonly those with 46,XY complete gonadal dysgenesis (Swyer syndrome), 45,X/46,XY mixed gonadal dysgenesis, or other forms of gonadal dysgenesis. The tumor is composed of a mixture of germ cells and sex cord-stromal cells resembling immature Sertoli and granulosa cells, typically arising in dysgenetic (streak) gonads. Gonadoblastoma itself is considered a benign or in situ neoplasm, but it carries significant c
Which specialists treat Gonadoblastoma?
15 specialists and care centers treating Gonadoblastoma are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.